Table 2 Summary of models considered with NAFLD fibrosis outcomes at 24 years

1

Sex

Sex

2

BMI

Sex, BMI (log)

3

Central adiposity

Sex, BMI (log), WCHt ratio

4

Steatosis

Sex, BMI (log), steatosis^a

5

Dyslipidaemia

Sex, BMI (log), triglycerides(log), cholesterol, LDL-C, VLDL-C, HDL-C

6

Insulin resistance

Sex, BMI (log), HOMA-IR

7

Hypertension

Sex, BMI (log), systolic BP, diastolic BP

8

Cardiometabolic

Sex, BMI (log), triglycerides(log), cholesterol, LDL-C, VLDL-C, HDL-C, HOMA-IR, systolic BP, diastolic BP

9

Liver enzymes

Sex, BMI (log), ALT (log), AST (log), GGT (log)

10

Cardiometabolic and liver enzymes

Sex, BMI (log), WCHt ratio, triglycerides(log), cholesterol, LDL-C, VLDL-C, HDL-C, HOMA-IR, systolic BP, diastolic BP, ALT (log), AST (log), GGT (log)

11

Routine clinical measures

Sex, BMI (log), WCHt ratio, steatosis^a, triglycerides(log), cholesterol, LDL-C, VLDL-C, HDL-C, HOMA-IR, systolic BP, diastolic BP, ALT (log), AST (log), GGT (log)